Idexx Laboratories catapulted to a record high Monday after the vet diagnostics outlet beat quarterly forecasts and boosted ...

Baron Funds, an investment management company, released its “Baron Asset Fund” third-quarter 2025 investor letter. A copy of ...

IDEXX Laboratories' stock narrative has seen a notable shift recently, as analysts update their outlook and raise the fair ...

For full-year 2025, Idexx now believes it will earn $4.27 billion to $4.3 billion in revenue, and earnings per share (EPS) of ...

IDEXX Laboratories recently reported strong third-quarter results, with revenue of US$1,105.24 million and net income of US$274.61 million, as well as raising its full-year 2025 revenue and EPS ...

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership ...

IDEXX Laboratories is a global company that provides products and services for primarily companion animals. Revenue has grown at a rate of 10%, driven by improving market conditions and an expansion ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the ...

IDEXX Laboratories, Inc. IDXX is set to release second quarter 2023 results on Aug 1 before the opening bell. The company posted adjusted earnings per share (EPS) of $2.55 in the last reported quarter ...

IDEXX Laboratories, Inc. IDXX is set to release fourth-quarter 2023 results on Feb 5 before the opening bell. The company posted adjusted earnings per share (EPS) of $2.53 in the last reported quarter ...